| Bafna Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532989 |
NSE Symbol : BAFNAPH |
P/E(TTM) : 137.07 |
|
ISIN Demat : INE878I01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.29 |
|
Book Value(₹) : 40.64 |
Market Cap(₹Cr) : 1,066.78 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 150.62 | 145.86 | 152.47 | 115.35 | 85.14 |
| Other Income | 4.76 | 2.74 | 3.52 | 3.27 | 1.70 |
| Stock Adjustments | 0.16 | -6.45 | 4.85 | 2.91 | 1.77 |
| Total Income | 155.54 | 142.15 | 160.84 | 121.53 | 88.61 |
| EXPENDITURE : | |||||
| Raw Materials | 82.14 | 74.49 | 91.58 | 65.98 | 41.70 |
| Power and Fuel Cost | 7.30 | 7.72 | 6.73 | 5.31 | 3.93 |
| Other Manufacturing Expenses | 13.52 | 14.83 | 13.83 | 8.68 | 7.72 |
| Selling and Administration Expenses | 9.56 | 9.37 | 13.98 | 5.39 | 6.92 |
| Miscellaneous Expenses | 0.40 | 2.94 | 1.06 | 1.33 | 2.19 |
| Employee Benefit Expenses | 21.92 | 21.03 | 19.03 | 15.87 | 14.65 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 20.70 | 11.77 | 14.63 | 18.99 | 11.50 |
| Interest | 3.66 | 2.73 | 2.29 | 2.04 | 0.79 |
| Gross Profit | 17.04 | 9.04 | 12.34 | 16.95 | 10.71 |
| Depreciation | 6.07 | 4.89 | 5.00 | 5.33 | 5.49 |
| Profit Before Tax | 10.97 | 4.15 | 7.34 | 11.62 | 5.22 |
| Current Tax | -0.13 | 0.00 | 0.00 | 0.28 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 11.10 | 4.15 | 7.35 | 11.34 | 5.22 |
| Extraordinary Items | 0.00 | -2.22 | 0.07 | 0.20 | -2.16 |
| Adjusted Net Profit | 11.10 | 6.37 | 7.28 | 11.14 | 7.38 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.04 | 0.15 | -0.02 |
| Profit/Loss Balance carried down | -43.11 | -47.26 | -54.48 | -65.97 | -71.17 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -32.01 | -43.11 | -47.10 | -54.48 | -65.97 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 4.69 | 1.76 | 3.11 | 4.79 | 2.21 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 40.64 | 35.85 | 34.17 | 31.05 | 26.19 |
| Book Value(Adj)-Unit Curr | 40.64 | 35.85 | 34.17 | 31.05 | 26.19 |
